Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026)
Alpha Teknova (TKNO) reported Cash from Investing Activities of $1.8 million for Q1 2026, down 51.86% year-over-year from $3.8 million in Q1 2025, and down 42.59% quarter-over-quarter from $3.2 million in Q4 2025.
Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Cash from Investing Activities data on file, last reported at $1.8 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $1.8 million, down 51.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 million (up 137.15% YoY), and the FY2025 annual result was $10.7 million, up 139.23% from the prior year.
- Cash from Investing Activities declined to $1.8 million in Q1 2026 per TKNO's latest filing, from $3.2 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $3.8 million in Q1 2025 and troughed at -$25.8 million in Q3 2024.
- A 5-year average of -$3.0 million and a median of -$972000.0 in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities slumped 2550.1% in 2024, then soared 29315.38% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$4.7 million in 2022, then surged by 97.57% to -$115000.0 in 2023, then sank by 1129.57% to -$1.4 million in 2024, then soared by 326.8% to $3.2 million in 2025, then sank by 42.59% to $1.8 million in 2026.
- Business Quant data shows TKNO's Cash from Investing Activities at $1.8 million in Q1 2026, $3.2 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Alpha Teknova | 239.62 Mn | 221.84 Mn | 3.78 Mn | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.84 Mn |
| Mar 31, 2026 | 1.84 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Sep 30, 2024 | -25.76 Mn |
| Sep 30, 2024 | -25.76 Mn |
| Jun 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | -115,000.00 |
| Dec 31, 2023 | -115,000.00 |